The 11 streaming platforms Americans watch most on their TVs — with YouTube on topByBruce GilPublishedJuly 11, 2024
A Quaker Oats facility might have had salmonella contamination for years, FDA saysByBruce GilPublishedJuly 10, 2024
Patients taking Ozempic for weight loss typically stop using it within 2 years, analysis findsByBruce GilPublishedJuly 10, 2024
Now playing Samsung's new Galaxy Ring will provide users with AI-powered health insightsPublishedJuly 10, 2024
Now playing Samsung just launched the Galaxy Ring, an AI-powered competitor to Oura smart ringsByBruce GilPublishedJuly 10, 2024
Who is David Ellison? Meet Hollywood's newest mogul and the next head of ParamountByBruce GilPublishedJuly 9, 2024
Eli Lilly's latest deal added $200 million to a Harvard professor's billion-dollar fortuneByBruce GilPublishedJuly 9, 2024
Eli Lilly's Mounjaro is more effective at weight loss than Novo Nordisk's Ozempic and Wegovy, study findsByBruce GilPublishedJuly 9, 2024
A 'flight from hell' had to make an emergency landing after a 'mass brawl' in midairByBruce GilPublishedJuly 8, 2024
Ozempic and other GLP-1 drugs could reduce risk of cancer for diabetes patients, study saysByBruce GilPublishedJuly 5, 2024
A third of millennials and Gen Z-ers would take a pay cut for more time with their petsByBruce GilPublishedJuly 5, 2024
Netflix, Disney and Paramount are fighting Canada's new streaming taxByBruce GilPublishedJuly 5, 2024
Ozempic could make low- or even alcohol-free beer and wine a lot more popularByBruce GilPublishedJuly 5, 2024
Stranger Things, The Crown, and One Piece: The 10 most expensive Netflix series ever madeByBruce GilPublishedJuly 5, 2024
Ozempic could be linked to a common cause of sudden blindness, study saysByBruce GilPublishedJuly 3, 2024
Jeff Bezos is selling $5 billion worth of Amazon stock — his fourth sale this yearByBruce GilPublishedJuly 3, 2024
A Wegovy ad was the third most seen television commercial this past JuneByBruce GilPublishedJuly 2, 2024
